AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2016

May 13, 2016

32093_dirs_2016-05-13_0cf17d7a-098b-4f2c-afdb-0a971aa64791.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2016-05-13

Reporting Person: UECKER DARRIN (Director, CEO and President)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$4.00	2025-09-08	Common Stock (281534)		Direct

Footnotes

F1: 25% of the shares subject to the option will vest on September 8, 2016, and the remaining shares will vest in equal quarterly installments thereafter over the following three year period, subject to the Reporting Person's continued service through each vesting date.